TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Bioform AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
15,152
|
14,101
|
8,373 |
| Financial expenses |
151
|
91
|
93 |
| Earnings before taxes |
5,903
|
5,745
|
536 |
| Total assets |
20,541
|
13,694
|
11,642 |
| Current assets |
15,528
|
11,347
|
9,975 |
| Current liabilities |
3,098
|
1,365
|
3,463 |
| Equity capital |
16,183
|
12,329
|
8,180 |
| - share capital |
441
|
464
|
495 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
78.8%
|
90.0%
|
70.3% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
39.0%
|
40.7%
|
6.4% |
| Return on assets (ROA) |
29.5%
|
42.6%
|
5.4% |
| Current ratio |
501.2%
|
831.3%
|
288.0% |
| Return on equity (ROE) |
36.5%
|
46.6%
|
6.6% |
| Change turnover |
1,759
|
6,243
|
-1,987 |
| Change turnover % |
13%
|
79%
|
-19% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.